Diabetic Gastroparesis Study 05

NCT03786380 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

202

Enrollment

INDUSTRY

Sponsor class

Stopped The Relamorelin program is being terminated solely based on a business decision.

Conditions

Gastroparesis

Interventions

DRUG: Relamorelin 10 μg

Sponsor

Allergan